• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Maehara Natsumi  前原 奈都美

ORCIDConnect your ORCID iD *help
Researcher Number 90783621
Other IDs
Affiliation (Current) 2026: 一般社団法人AIM医学研究所, 分子病態医科学研究部門, シニアリサーチフェロー
Affiliation (based on the past Project Information) *help 2025: 一般社団法人AIM医学研究所, 分子病態医科学研究部門, シニアリサーチフェロー
2023: 一般社団法人AIM医学研究所, 研究部門, シニアリサーチフェロー
2021 – 2022: 東京大学, 大学院医学系研究科(医学部), 客員研究員
2018 – 2020: 東京大学, 大学院医学系研究科(医学部), 助教
2017: 大阪大学, 医学系研究科, 特任研究員(常勤)
Review Section/Research Field
Principal Investigator
Basic Section 49010:Pathological biochemistry-related / Pathological medical chemistry
Keywords
Principal Investigator
CD5L / AIM / NAMPs / ALS / 神経再生 / 死細胞塊 / セルフ・パソジェン / DAMPs / 脳梗塞 / アルツハイマー … More / セルフパソジェン / アミロイドベータ / アルツハイマー病 / 癌 / 線維芽細胞 / AOM/DSS / 炎症性腸疾患 / 炎症性大腸炎 / 潰瘍性大腸炎 / 大腸がん / Wnt5a Less
  • Research Projects

    (4 results)
  • Research Products

    (3 results)
  • Co-Researchers

    (1 People)
  •  組織マクロファージ特異的因子を用いたALS新規疾患修飾薬の創出基盤研究Principal Investigator

    • Principal Investigator
      前原 奈都美
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 49010:Pathological biochemistry-related
    • Research Institution
      The Institute for AIM Medicine
  •  AIM/CD5L ameliorates ischemic stroke by suppressing DAMPs-mediated sterile inflammation and promoting neurogenesisPrincipal Investigator

    • Principal Investigator
      Maehara Natsumi
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 49010:Pathological biochemistry-related
    • Research Institution
      The Institute for AIM Medicine
      The University of Tokyo
  •  AIM/CD5L attenuates Amyloid beta at the Alzheimer's disease and prevents dementiaPrincipal Investigator

    • Principal Investigator
      Maehara Natsumi
    • Project Period (FY)
      2019 – 2020
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 49010:Pathological biochemistry-related
    • Research Institution
      The University of Tokyo
  •  Wnt5a expression in cancer-associated fibroblasts promotes colitis-associated tumor formationPrincipal Investigator

    • Principal Investigator
      Maehara Natsumi
    • Project Period (FY)
      2017 – 2018
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Pathological medical chemistry
    • Research Institution
      The University of Tokyo
      Osaka University

All 2021 2017

All Journal Article Presentation

  • [Journal Article] AIM/CD5L attenuates DAMPs in the injured brain and thereby ameliorates ischemic stroke2021

    • Author(s)
      Natsumi Maehara, Kaori Taniguchi, Ami Okuno, Hideaki Ando, Aika Hirota, Zhiheng Li, Ching-Ting Wang, Satoko Arai, Toru Miyazaki
    • Journal Title

      Cell reports

      Volume: 36 Issue: 11 Pages: 109693-109693

    • DOI

      10.1016/j.celrep.2021.109693

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K06867
  • [Presentation] AIM/CD5Lによる脳梗塞病態の制御機構解明2021

    • Author(s)
      Natsumi Maehara, Kaori Taniguchi, Ami Okuno, Hideaki Ando, Aika Hirota, Zhiheng Li, Ching-Ting Wang, Satoko Arai, Toru Miyazaki
    • Organizer
      分子生物学会
    • Data Source
      KAKENHI-PROJECT-21K06867
  • [Presentation] 腸管炎症関連疾患におけるWnt5aの機能解析2017

    • Author(s)
      前原 奈都美
    • Organizer
      2017年度生命科学系学会合同年次大会
    • Data Source
      KAKENHI-PROJECT-17K15619
  • 1.  KIKUCHI Akira
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi